Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8274749 | Journal of the Neurological Sciences | 2016 | 25 Pages |
Abstract
Several reports in the literature suggest that retinoids are involved in proteostasis regulation, by modulating its two major pathways, the ubiquitin-proteasome system and the autophagy-lysosome response. Additionally, there are some evidences for a role of retinoids themselves, in ALS pathogenesis. In this review, we discuss the importance of proteostasis disruption as a trigger for MN degeneration and the capability of retinoids to modulate it, as well as the potential therapeutic role of retinoids as a new therapy in ALS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Javier Riancho, Maria T. Berciano, Maria Ruiz-Soto, Jose Berciano, Gary Landreth, Miguel Lafarga,